European Journal of Clinical Pharmacology

, Volume 71, Issue 12, pp 1429–1440 | Cite as

Medications associated with falls in older people: systematic review of publications from a recent 5-year period

  • Hyerim Park
  • Hiroki Satoh
  • Akiko Miki
  • Hisashi Urushihara
  • Yasufumi SawadaEmail author



Falls are an important public health problem in older people. Medication use is considered a risk factor for falls. This study systematically reviewed recent studies to determine the medications that might be associated with the risk of falling in older people.


We conducted a systematic review of prospective and retrospective studies identified through the MEDLINE and CINAHL databases that quantitatively assessed the contribution of medications to falls risk in participants ≥60 years old published in English between May 2008 and April 2013.


The search identified 1,895 articles; 36 articles met the inclusion criteria. Of the 19 studies that investigated the effect of polypharmacy on the risk of falling, six studies reported that the risk of falling increased with polypharmacy. Data on the use of antihypertensive medications including calcium channel blockers, beta-blockers, and angiotensin system blocking medications were collected in 14 studies, with mixed results. Twenty-nine studies reported an association between the risk of falls and psychotropic medications including sedatives and hypnotics, antidepressants, and benzodiazepines.


The use of sedatives and hypnotics and antidepressants including tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin norepinephrine reuptake inhibitors appears to be related with an increased risk of falls. It is not clear if the use of antihypertensive medications is associated with the risk of falls in older people.


Accidental falls Pharmaceutical preparations Aged Systematic review 



This review and the preparation of the manuscript were not supported by any external funding.

Conflict of interest

HU is a paid consultant of Eli Lilly Japan and Eisai Co., Ltd. The other authors declare that they have no conflict of interest.


  1. 1.
    Masud T, Morris RO (2001) Epidemiology of falls. Age Ageing 30:3–7CrossRefPubMedGoogle Scholar
  2. 2.
    World Health Organization (2007) WHO global report on falls prevention in older age. Accessed 22 April 2014.
  3. 3.
    Wilson IB, Schoen C, Neuman P, Strollo MK, Rogers WH, Chang H, Safran DG (2007) Physician-patient communication about prescription medication nonadherence: a 50-state study of America’s seniors. J Gen Intern Med 22:6–12PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47:30–39CrossRefPubMedGoogle Scholar
  5. 5.
    Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 47:40–50CrossRefPubMedGoogle Scholar
  6. 6.
    Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960CrossRefPubMedGoogle Scholar
  7. 7.
    Hartikainen S, Lönnroos E, Louhivuori K (2007) Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 62:1172–1181CrossRefPubMedGoogle Scholar
  8. 8.
    Darowski A, Chambers SA, Chambers DJ (2009) Antidepressants and falls in the elderly. Drugs Aging 26:381–394CrossRefPubMedGoogle Scholar
  9. 9.
    Lamb SE, Jørstad-Stein EC, Hauer K, Becker C, Prevention of Falls Network Europe and Outcomes Consensus Group (2005) Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 53:1618–1622CrossRefPubMedGoogle Scholar
  10. 10.
    Gibson MJ, Andres RO, Isaacs B, Radebaugh T, Worm-Petersen J (1987) The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull 34:1–24Google Scholar
  11. 11.
    Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707CrossRefPubMedGoogle Scholar
  12. 12.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMedGoogle Scholar
  13. 13.
    Lackner TE, Wyman JF, McCarthy TC, Monigold M, Davey C (2008) Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc 56:862–870CrossRefPubMedGoogle Scholar
  14. 14.
    Pellfolk T, Gustafsson T, Gustafson Y, Karlsson S (2009) Risk factors for falls among residents with dementia living in group dwellings. Int Psychogeriatr 21:187–194CrossRefPubMedGoogle Scholar
  15. 15.
    Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, Mason RS, Chen JS, Cumming RG, Sambrook PN (2011) Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 59:875–880CrossRefPubMedGoogle Scholar
  16. 16.
    Anstey KJ, Burns R, von Sanden C, Luszcz MA (2008) Psychological well-being is an independent predictor of falling in an 8-year follow-up of older adults. J Gerontol B Psychol Sci Soc Sci 63:P249–P257CrossRefPubMedGoogle Scholar
  17. 17.
    Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, Flicker L (2011) Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 71:592–599PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG (2012) Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65:989–995CrossRefPubMedGoogle Scholar
  20. 20.
    Iinattiniemi S, Jokelainen J, Luukinen H (2009) Falls risk among a very old home-dwelling population. Scand J Prim Health Care 27:25–30PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Kojima T, Akishita M, Nakamura T, Nomura K, Ogawa S, Iijima K, Eto M, Ouchi Y (2012) Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int 12:425–430CrossRefPubMedGoogle Scholar
  22. 22.
    Roig M, Eng JJ, MacIntyre DL, Road JD, FitzGerald JM, Burns J, Reid WD (2011) Falls in people with chronic obstructive pulmonary disease: an observational cohort study. Respir Med 105:461–469PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Sylliaas H, Selbaek G, Bergland A (2012) Do behavioral disturbances predict falls among nursing home residents? Aging Clin Exp Res 24:251–256CrossRefPubMedGoogle Scholar
  24. 24.
    Verghese J, Holtzer R, Lipton RB, Wang C (2009) Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci 64:896–901CrossRefPubMedGoogle Scholar
  25. 25.
    von Heideken WP, Gustafson Y, Kallin K, Jensen J, Lundin-Olsson L (2009) Falls in very old people: the population-based Umeå 85+ study in Sweden. Arch Gerontol Geriatr 49:390–396CrossRefGoogle Scholar
  26. 26.
    Whitney J, Close JC, Lord SR, Jackson SH (2012) Identification of high risk fallers among older people living in residential care facilities: a simple screen based on easily collectable measures. Arch Gerontol Geriatr 55:690–695CrossRefPubMedGoogle Scholar
  27. 27.
    Wong AK, Lord SR, Sturnieks DL, Delbaere K, Trollor JN, Close JC (2013) Angiotensin system-blocking medications are associated with fewer falls over 12 months in community-dwelling older people. J Am Geriatr Soc 61:776–781CrossRefPubMedGoogle Scholar
  28. 28.
    Damián J, Pastor-Barriuso R, Valderrama-Gama E, de Pedro-Cuesta J (2013) Factors associated with falls among older adults living in institutions. BMC Geriatr 13:6PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Neumann L, Hoffmann VS, Golgert S, Hasford J, Von Renteln-Kruse W (2013) In-hospital fall-risk screening in 4,735 geriatric patients from the LUCAS project. J Nutr Health Aging 17:264–269CrossRefPubMedGoogle Scholar
  30. 30.
    Spoelstra SL, Given BA, Schutte DL, Sikorskii A, You M, Given CW (2013) Do older adults with cancer fall more often? A comparative analysis of falls in those with and without cancer. Oncol Nurs Forum 40:E69–E78CrossRefPubMedGoogle Scholar
  31. 31.
    van Strien AM, Koek HL, van Marum RJ, Emmelot-Vonk MH (2013) Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas 74:357–362CrossRefPubMedGoogle Scholar
  32. 32.
    Yamashita T, Jeon H, Bailer AJ, Nelson IM, Mehdizadeh S (2011) Fall risk factors in community-dwelling elderly who receive Medicaid-supported home- and community-based care services. J Aging Health 23:682–703CrossRefPubMedGoogle Scholar
  33. 33.
    Boutin T, Kergoat MJ, Latour J, Massoud F, Kergoat H (2012) Vision in the global evaluation of older individuals hospitalized following a fall. J Am Med Dir Assoc 13:187, e15–19 CrossRefPubMedGoogle Scholar
  34. 34.
    Chang CM, Chen MJ, Tsai CY, Ho LH, Hsieh HL, Chau YL, Liu CY (2011) Medical conditions and medications as risk factors of falls in the inpatient older people: a case–control study. Int J Geriatr Psychiatry 26:602–607CrossRefPubMedGoogle Scholar
  35. 35.
    Gribbin J, Hubbard R, Gladman JR, Smith C, Lewis S (2010) Risk of falls associated with antihypertensive medication: population-based case–control study. Age Ageing 39:592–597CrossRefPubMedGoogle Scholar
  36. 36.
    Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S (2011) Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case–control and case-series analysis of a large UK primary care database. Drugs Aging 28:895–902CrossRefPubMedGoogle Scholar
  37. 37.
    Mamun K, Lim JK (2009) Association between falls and high-risk medication use in hospitalized Asian elderly patients. Geriatr Gerontol Int 9:276–281CrossRefPubMedGoogle Scholar
  38. 38.
    Modén B, Merlo J, Ohlsson H, Rosvall M (2010) Psychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden. J Epidemiol Community Health 64:440–446CrossRefPubMedGoogle Scholar
  39. 39.
    Nanda S, Dey T, Gulstrand RE Jr, Cudnik D, Haller HS (2011) Fall Risk Assessment in Geriatric-Psychiatric Inpatients to Lower Events (FRAGILE). J Gerontol Nurs 37:22–30CrossRefPubMedGoogle Scholar
  40. 40.
    Rhalimi M, Helou R, Jaecker P (2009) Medication use and increased risk of falls in hospitalized elderly patients: a retrospective, case–control study. Drugs Aging 26:847–852CrossRefPubMedGoogle Scholar
  41. 41.
    Agashivala N, Wu WK (2009) Effects of potentially inappropriate psychoactive medications on falls in US nursing home residents: analysis of the 2004 National Nursing Home Survey database. Drugs Aging 26:853–860CrossRefPubMedGoogle Scholar
  42. 42.
    Azidah AK, Hasniza H, Zunaina E (2012) Prevalence of falls and its associated factors among elderly diabetes in a tertiary center, Malaysia. Curr Gerontol Geriatr Res 2012:539073PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Ferrer A, Formiga F, Plana-Ripoll O, Tobella MA, Gil A, Pufol R, Octabaix Study Group (2012) Risk of falls in 85-year-olds is associated with functional and cognitive status: the Octabaix Study. Arch Gerontol Geriatr 54:352–356CrossRefPubMedGoogle Scholar
  44. 44.
    Lee JS, Hui E, Chan F, Chi I, Woo J (2008) Associated factors of falls in nursing home residents in Hong Kong and the role of restraints: a cross-sectional survey using the Resident Assessment Instrument (RAI) 2.0. Aging Clin Exp Res 20:447–453CrossRefPubMedGoogle Scholar
  45. 45.
    Masud T, Frost M, Ryg J, Matzen L, Ibsen M, Abrahamsen B, Brixen K (2013) Central nervous system medications and falls risk in men aged 60–75 years: the Study on Male Osteoporosis and Aging (SOMA). Age Ageing 42:121–124CrossRefPubMedGoogle Scholar
  46. 46.
    Shin KR, Kang Y, Hwang EH, Jung D (2009) The prevalence, characteristics and correlates of falls in Korean community-dwelling older adults. Int Nurs Rev 56:387–392CrossRefPubMedGoogle Scholar
  47. 47.
    Ackroyd-Stolarz S, Mackinnon NJ, Sketris I, Sabo B (2009) Potentially inappropriate prescribing of benzodiazepines for older adults and risk of falls during a hospital stay: a descriptive study. Can J Hosp Pharm 62:276–283PubMedCentralPubMedGoogle Scholar
  48. 48.
    Yu PL, Qin ZH, Shi J, Zhang J, Xin MZ, Wu ZL, Sun ZQ (2009) Prevalence and related factors of falls among the elderly in an urban community of Beijing. Biomed Environ Sci 22:179–187CrossRefPubMedGoogle Scholar
  49. 49.
    Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E (2010) Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 21:658–668CrossRefPubMedGoogle Scholar
  50. 50.
    Deandrea S, Bravi F, Turati F, Lucenteforte E, La Vecchia C, Negri E (2013) Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr 56:407–415CrossRefPubMedGoogle Scholar
  51. 51.
    Federal Interagency Forum on Aging-Related Statistics (2012) Older Americans 2012: key indicators of well-being. U.S. Government Printing Office, Washington, DC, Accessed 7 July 2015Google Scholar
  52. 52.
    Gurwitz JH (2004) Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 164:1957–1959CrossRefPubMedGoogle Scholar
  53. 53.
    Hohl CM, Dankoff J, Colacone A, Afilalo M (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 38:666–671CrossRefPubMedGoogle Scholar
  54. 54.
    Lin P (2003) Drug interactions and polypharmacy in the elderly. Can Alzheimer Dis Rev, pp 10–14. Accessed 9 October 2014.
  55. 55.
    Salazar JA, Poon I, Nair M (2007) Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 6:695–704CrossRefPubMedGoogle Scholar
  56. 56.
    Gu Q, Burt VL, Dillon CF, Yoon S (2012) Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 126:2105–2114CrossRefPubMedGoogle Scholar
  57. 57.
    Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä SL, Isoaho R (2002) Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55:809–817CrossRefPubMedGoogle Scholar
  58. 58.
    Sra JS, Murthy V, Natale A, Jazayeri MR, Dhala A, Deshpande S et al (1994) Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. Am J Cardiol 73:33–37CrossRefPubMedGoogle Scholar
  59. 59.
    Tomaschitz A, Pilz S, Ritz E et al (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 411:1354–1360CrossRefPubMedGoogle Scholar
  60. 60.
    Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R (2008) Opioid complications and side effects. Pain Physician 11:S105–S120PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Hyerim Park
    • 1
  • Hiroki Satoh
    • 1
  • Akiko Miki
    • 1
  • Hisashi Urushihara
    • 2
  • Yasufumi Sawada
    • 1
    Email author
  1. 1.Endowed Laboratory of Drug Lifetime Management, Graduate School of Pharmaceutical SciencesThe University of TokyoTokyoJapan
  2. 2.Division of Drug Development and Regulatory Science, Faculty of PharmacyKeio UniversityTokyoJapan

Personalised recommendations